Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3500759016 | Pyrimethamine 25 mg and sulfadoxine 500 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3682463016 | Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
46700901000001117 | Sulfadoxine 500mg / Pyrimethamine 25mg tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
62045401000001115 | Pyrimethamine 25mg / Sulfadoxine 500mg tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Is a | Product containing pyrimethamine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Is a | Product containing sulfadoxine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Is a | Product containing pyrimethamine and sulfadoxine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has active ingredient | Pyrimethamine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has active ingredient | Sulfadoxine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has active ingredient | Bactericide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Is a | Product containing pyrimethamine and sulfadoxine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has active ingredient | Sulfadoxine | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Sulfadoxine | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has active ingredient | Pyrimethamine | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Pyrimethamine | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Pyrimethamine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Sulfadoxine | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Sulfadoxine | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Pyrimethamine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Is a | Product containing only pyrimethamine and sulfadoxine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Plays role | Antimalarial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Is a | Pyrimethamine + Sulfadoxine | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has active ingredient | Pyrimethamine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has active ingredient | Sulfadoxine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has specific active ingredient | Pyrimethamine | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has specific active ingredient | Sulfadoxine | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Pyrimethamine+sulfadoxine 25mg/500mg tablet - product | Is a | False | Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Fansidar tablets (Roche Products Ltd) | Is a | True | Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sulfadoxine 500mg / Pyrimethamine 25mg tablets 3 tablet | Is pack of | False | Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Sulfadoxine 500mg / Pyrimethamine 25mg tablets 3 tablet | Has VMP | True | Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets